DK0769962T3 - Fremgangsmåde til afsvækkelse af arteriel stenose - Google Patents

Fremgangsmåde til afsvækkelse af arteriel stenose

Info

Publication number
DK0769962T3
DK0769962T3 DK95925386T DK95925386T DK0769962T3 DK 0769962 T3 DK0769962 T3 DK 0769962T3 DK 95925386 T DK95925386 T DK 95925386T DK 95925386 T DK95925386 T DK 95925386T DK 0769962 T3 DK0769962 T3 DK 0769962T3
Authority
DK
Denmark
Prior art keywords
attenuating
procedure
arterial stenosis
tfpi
hours
Prior art date
Application number
DK95925386T
Other languages
English (en)
Inventor
D Washington Uty S Abendschein
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0769962T3 publication Critical patent/DK0769962T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices For Medical Bathing And Washing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95925386T 1994-07-07 1995-07-06 Fremgangsmåde til afsvækkelse af arteriel stenose DK0769962T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27193094A 1994-07-07 1994-07-07
PCT/US1995/008221 WO1996001649A1 (en) 1994-07-07 1995-07-06 Method of attenuating arterial stenosis

Publications (1)

Publication Number Publication Date
DK0769962T3 true DK0769962T3 (da) 2003-06-23

Family

ID=23037681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95925386T DK0769962T3 (da) 1994-07-07 1995-07-06 Fremgangsmåde til afsvækkelse af arteriel stenose

Country Status (10)

Country Link
EP (1) EP0769962B1 (da)
JP (2) JP4065557B2 (da)
AT (1) ATE235252T1 (da)
AU (1) AU2953795A (da)
CA (1) CA2194443A1 (da)
DE (1) DE69530084T2 (da)
DK (1) DK0769962T3 (da)
ES (1) ES2196067T3 (da)
PT (1) PT769962E (da)
WO (1) WO1996001649A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200506B2 (en) * 1995-06-07 2007-01-18 G.D. Searle Llc Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
DE69635051T2 (de) 1995-06-07 2006-06-14 Chiron Corp Methode zur lösung, reinigung und rückfaltung von protein
WO2005019265A1 (en) 2003-08-13 2005-03-03 Chiron Corporation Improved method of purifying tfpi and tfpi analogs
JP5306179B2 (ja) * 2007-03-20 2013-10-02 出光興産株式会社 スパッタリングターゲット、酸化物半導体膜及び半導体デバイス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0465557A (ja) * 1990-06-28 1992-03-02 Unitika Ltd 起毛編物の製造方法
DE69118056T2 (de) * 1990-08-27 1996-10-24 Monsanto Co Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
AU4408493A (en) * 1992-06-11 1994-01-04 Washington University Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders

Also Published As

Publication number Publication date
ES2196067T3 (es) 2003-12-16
DE69530084T2 (de) 2004-02-05
DE69530084D1 (de) 2003-04-30
CA2194443A1 (en) 1996-01-25
WO1996001649A1 (en) 1996-01-25
JP4065557B2 (ja) 2008-03-26
ATE235252T1 (de) 2003-04-15
AU2953795A (en) 1996-02-09
JPH10502639A (ja) 1998-03-10
PT769962E (pt) 2003-07-31
JP2008007512A (ja) 2008-01-17
EP0769962A1 (en) 1997-05-02
EP0769962B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
ZA962275B (en) Carboxyalkylethers formulations and treatment of vascular diseases
HUT72317A (en) Use of venflaxine or 3-aryloxi-propaneamine derivatives for preparing pharmaceutical compositions for treatment of incontinence
CA2238098A1 (en) Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis
DK1920764T3 (da) Fluprostenolisopropylester til anvendelse i behandling af glaukom og okulær hypertension
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
UA43391C2 (uk) Спосіб інгібування міжклітинного зчеплення і спосіб інгібування запального процесу та порушеного процесу нормальної коагуляції у пацієнтів з розладами васкулярного ендотелію
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
WO2004024093A3 (en) Device and method for treating restenosis
DE69422707D1 (de) Verfahren zur verhinderung der trübung der hinteren linsenkapsel
UA84665C2 (ru) Способ ингибирования опосредствованного ангиогенеза в ткани у пациента с неоваскулярным заболеванием роговицы
DK0563023T3 (da) Anvendelse af vævsfaktor pathway inhibitor til fremstilling af et medikament til anvendelse ved en fremgangsmåde til hæmnin
AU631738B2 (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
LV11728A (lv) Farmaceitiska kompozicija
DK0769962T3 (da) Fremgangsmåde til afsvækkelse af arteriel stenose
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
WO2003045311A3 (en) Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
DE69421694D1 (en) Interleukin-1 inhibitor
GR3021171T3 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.